title: Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.
authors.forename: P D
authors.initials: PD
authors.lastname: Stein
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: S
authors.initials: S
authors.lastname: Goldman
authors.forename: L
authors.initials: L
authors.lastname: Schwartz
authors.forename: A G
authors.initials: AG
authors.lastname: Turpie
authors.forename: P
authors.initials: P
authors.lastname: Théroux
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D007387:Internal Mammary-Coronary Artery Anastomosis; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012501:Saphenous Vein / Q000637:transplantation; D013442:Sulfinpyrazone / Q000627:therapeutic use; D015912:Thrombolytic Therapy
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D013442:Sulfinpyrazone